From solid tumors to metastatic carcinomas and leukemia: cancer is among the most common causes of death and has many faces. Keep reading for latest developments in early detection, staging, therapy and research.
Surgery for vulvar cancer can save lives, but also significantly affect a woman's sexual function and quality of life. Now, a new surgical technique makes it possible to restore the clitoris.
Early detection of ovarian cancer is difficult as precursor lesions can be microscopic and hard to sample. To address this, researchers developed a handheld device that can gently collect living cells from specific locations to test for ovarian and other cancers.
Could a patient's sweet tooth sabotage antibiotic treatment for blood cancer? A study suggests that eating less sugar could protect the microbiome during allogeneic hematopoietic cell transplant.
Using implanted collagen tiles during brain surgery, a new kind of radiation therapy (TBRT) could significantly lower the risk of recurrence in brain metastases, a new study finds.
DNA methylation patterns in blood could identify people at high risk of prostate or breast cancer up to eight years before diagnosis, Oxford Population Health researchers report.
A Cambridge study reveals how tumours suppress immune responses – and how blocking this mechanism could make immunotherapies effective in more patients.
AI-enabled spatial analysis can identify patterns in routine pathology slides that may help clinicians identify which patients with pancreatic cancer are at greater risk of recurrence after treatment and surgery, a new study finds.
Monitoring blood test trends alongside unexplained weight loss can provide further clues about a patient’s risk of developing cancer, according to a new study.
A non-invasive urine test detected more than 9 in 10 bladder cancers in a large NHS study – and could reduce urgent cystoscopies significantly.
For many childhood cancers, chemotherapy is the only treatment option. A study explores the trade-off between life-saving treatment at a young age, and delayed side effects unfolding over a lifetime.
Radiotherapy may be able to do far more than simply destroy tumor cells. A review explores how combining radiotherapy with immunotherapy could improve outcomes for patients with pancreatic cancer.
In glioblastoma, the treatment order matters: a new study shows that administering cell immunotherapy before surgery to remove a brain tumour is significantly more effective than the other way around.
Exposure of the thymus to radiation during lung cancer treatment is linked to an increased risk of the cancer spreading to other parts of the body and overall worse outcomes, a new study finds.
Cancer metastasis is responsible for at least two-thirds of cancer deaths. Researchers have developed a multi-organ chip that mimics how cancer cells spread to distant organs to gain new insights.
On the way to a patient's “digital twin”: A novel, AI-powered virtual patient simulation system integrating multimodal data is designed to advance personalised cancer treatment.
Digital pathology and spatial omics could enable researchers to see how a tumor's different cell populations function, opening new perspectives for precision cancer therapy.
As TIL therapy remains difficult to access across Germany and Austria, Sheba offers more than 15 years of experience, in-house cell manufacturing, and one of the world's leading cellular therapy programs for advanced melanoma.
A new study has identified a way to reshape the gut microbiome that can enhance the delivery of certain chemotherapies to tumors, making these nanoparticle-based cancer drugs more effective.
As access to TIL therapy remains limited across Europe, Sheba Medical Center combines 15+ years of experience, in-house manufacturing, and pioneering research to advance melanoma and CAR-T therapies.
